Monocal Calcium and Fluoride Supplement Recalled for Excess Fluoride
Mericon Industries is recalling Monocal Calcium & Fluoride Supplement because it contains an excess amount of fluoride.
What this means for you
Minor labeling or packaging issue, or a voluntary precautionary recall. Risk of harm is low but real — follow the manufacturer's instructions.
Our severity reasoning: The recall is classified as FDA Class II, and the source text does not report any illnesses or injuries, fitting the criteria for a moderate severity score involving low-risk contamination or labeling issues.
Plain-English summary
Mericon Industries, Inc. is recalling 158 bottles of Monocal, Calcium & Fluoride Supplement, 100 Tablets. The product was manufactured in Peoria, Illinois, and is identified by Lot 73007 and UPC 0394-0105-02.
The recall was initiated because the dietary supplement contains an excess amount of fluoride. The affected units were distributed in North Carolina, Massachusetts, New Jersey, Wisconsin, Iowa, and to one customer in England.
Consumers who have this product should stop using it and contact the recalling firm for instructions on how to return the product or obtain a refund.
The recalled product
- Product
- Monocal, Calcium & Fluoride Supplement, 100 Tablets; Mericon Industries, Inc., Peoria, Illinois 61615; UPC: 0394-0105-02
- Manufacturer
- Mericon Industries Inc.
- Category
- Drug — Dietary Supplement
- Hazard
- Affected units
- 158
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (1)
- Lot: 73007
Distribution
Related recalls
Other drug recalls
- SevereZicam Cold Remedy Nasal Swabs Recalled for Microbiological Testing Failures
FDA (Drugs) · 2026-09-02
- HighAccord Recalls Subpotent Levothyroxine Sodium Tablets Nationwide
FDA (Drugs) · 2026-09-02
- ModerateLupin Recalls Clobetasol Propionate Cream for Content Uniformity Failures
FDA (Drugs) · 2026-09-02
- SevereAccord Recalls Subpotent Levothyroxine Sodium Tablets Nationwide
FDA (Drugs) · 2026-09-02
- HighAccord Healthcare Recalls Subpotent Levothyroxine Sodium Tablets Nationwide
FDA (Drugs) · 2026-09-02